Richter Gedeon Vegyszeti Stock Fundamentals

RIG2 Stock  EUR 26.14  0.34  1.28%   
Richter Gedeon Vegyszeti fundamentals help investors to digest information that contributes to Richter Gedeon's financial success or failures. It also enables traders to predict the movement of Richter Stock. The fundamental analysis module provides a way to measure Richter Gedeon's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Richter Gedeon stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Richter Gedeon Vegyszeti Company Return On Equity Analysis

Richter Gedeon's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Richter Gedeon Return On Equity

    
  0.25  
Most of Richter Gedeon's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Richter Gedeon Vegyszeti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Richter Gedeon Vegyszeti has a Return On Equity of 0.247. This is 101.03% lower than that of the Healthcare sector and 29.43% lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Germany stocks is 179.68% lower than that of the firm.

Richter Gedeon Vegyszeti Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Richter Gedeon's current stock value. Our valuation model uses many indicators to compare Richter Gedeon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Richter Gedeon competition to find correlations between indicators driving Richter Gedeon's intrinsic value. More Info.
Richter Gedeon Vegyszeti is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about  0.38  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Richter Gedeon Vegyszeti is roughly  2.62 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Richter Gedeon's earnings, one of the primary drivers of an investment's value.

Richter Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Richter Gedeon's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Richter Gedeon could also be used in its relative valuation, which is a method of valuing Richter Gedeon by comparing valuation metrics of similar companies.
Richter Gedeon is currently under evaluation in return on equity category among its peers.

Richter Fundamentals

About Richter Gedeon Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Richter Gedeon Vegyszeti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Richter Gedeon using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Richter Gedeon Vegyszeti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Richter Gedeon Vegyszeti Gyr Nyilvnosan Mukdo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company was founded in 1901 and is headquartered in Budapest, Hungary. RICHT GEDE operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12869 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Richter Stock

Richter Gedeon financial ratios help investors to determine whether Richter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Richter with respect to the benefits of owning Richter Gedeon security.